ENZBEnzo Biochem, Inc.

About Enzo Biochem, Inc. (ENZB)

Enzo Biochem, Inc. (ENZB) is a Diagnostics & Research company headquartered in Farmingdale, NY, United States whose shares trade over-the-counter on the OTCQX tier.

Enzo Biochem, Inc. has operated as a life sciences company for over 45 years. The primary business of Enzo today is conducted through its Life Sciences division, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins. The Company's proprietary products and technologies play central roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The Company monetizes its technology primarily via sales through our global distribution network and licensing. Enzo Life Sciences is operated through the Company's wholly-owned subsidiary Enzo Life Sciences, Inc. and its wholly-owned foreign subsidiaries.

Products and services

Enzo's broad spectrum of products, including labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect and visualize a biological target of interest in drug discovery exploration and drug development process development. Enzo leverages its differentiated capabilities in labeling and detection, assay kitting and validations, and integrated manufacturing to serve as a “one stop shop” for thousands of reagents that are critical to workflows across various technologies and applications, validated by over 160,000 scientific publications.

ENZB key facts

Ticker symbol

ENZB

Market tier

OTCQX

Sector

Healthcare

Industry

Diagnostics & Research

Headquarters

Farmingdale, NY, United States

Country of incorporation

US

Year of incorporation

1976

Employees

136

Estimated market cap

$25.63M (as of May 6, 2025)

Shares outstanding

52,299,941

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

7/31

Enzo Biochem, Inc. leadership

• Kara Cannon — CEO
• Patricia Eckert — CFO
• Michael Greubel — Counsel
• Adam Finerman — Outside Counsel
• Al Horcher — Corporate Controller

Explore more: Diagnostics & Research stocks · Healthcare sector · OTCQX stocks · OTC stocks starting with E